NEW YORK (GenomeWeb News) — Agilent Technologies plans to acquire Stratagene for around $246 million in cash, the companies said today.
 
Separately, Stratagene CEO Joseph Sorge plans to form a new company that will pay $6.6 million for some of Stratagene’s molecular diagnostics assets.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.